Abstract: 21st Century Drugs: Examining the Predictors of Synthetic Cannabinoid Use Among a Sample of Adolescents in Kentucky (Society for Social Work and Research 22nd Annual Conference - Achieving Equal Opportunity, Equity, and Justice)

549P 21st Century Drugs: Examining the Predictors of Synthetic Cannabinoid Use Among a Sample of Adolescents in Kentucky

Schedule:
Saturday, January 13, 2018
Marquis BR Salon 6 (ML 2) (Marriott Marquis Washington DC)
* noted as presenting author
Grant Victor, MSW, Doctoral Student, University of Kentucky, Lexington, KY
Jennifer Cole, PhD, Assistant Professor, University of Kentucky, Lexington, KY
TK Logan, PhD, Professor, University of Kentucky, Lexington, KY
Robert Walker, LCSW, Assistant Professor, University of Kentucky, Lexington, KY
Introduction:

Synthetic cannabinoid (SC) use related reports to poison centers from 2013 to 2015 increased from 2,668 to 7,779, and over the past year a threefold increase in reported deaths related to SC-use have occurred in the United States. SCs are an extensive, heterogeneous group of human-made chemicals, which are composed to mimic the effects of δ-9-tetrahydrocannabinol (THC) – the primary psychoactive chemical in marijuana. SCs include a host of chemicals that provide high-efficacy full agonists of the CB1 and/or CB2 cannabinoid receptors. Unlike traditional illicit drugs, SCs are available at convenience stores, gas stations, “smoke shops,” and online. SCs are particularly appealing to adolescents due to their perceived legality/harmlessness, their affordable cost, and their concealment in urine drug screens – especially for adolescents involved in the criminal justice system. Yet, to date there is little knowledge regarding the psychosocial predictors of SC-use among adolescents. This cross-sectional study aims to develop a SC-user descriptive profile and to assess predictors of SC-use among a sample of adolescents in Kentucky.

Methods:

Data and samples: Extant data was analyzed from three statewide samples of adolescents receiving treatment for substance abuse (N = 1,831) in 2014-2016. Data was collected by clinicians at intake, using a structured online survey tool (including inpatient, outpatient, and intensive outpatient).

Measures: Bivariate tests of association with past 12-month SC-use included gender, race, age, and referral status. Multivariate predictors of past 12-month SC-use consisted of variables from three behavioral health domains: 1) Substance use; 2) Interpersonal Victimization; and 3) Mental Health. Substance use and interpersonal victimization variables were based on client self-report over the past 12-months. Mental health measures were taken from three Pediatric Symptom Checklist-17 (PCS) subscales: 1) Attention Problems; 2) Internalizing Problems; and 3) Externalizing Problems. These subscales were operationalized by using cutoff points to indicate significant impairments.

Analyses: Descriptive analyses included raw percentages and cross-tabs chi-square bivariate tests. A binary logistic regression test was used to ascertain significant predictors of SC-use across the three psychosocial domains.

Results:

Overall 19.6% of clients reported SC-use. Caucasian males who were older the 16-years-of-age or older and that were court referred to treatment reported the greatest SC-use, although not significant at the bivariate-level. The binary logistic regression analysis, χ²(7, 1,824)=303.308, p<.000 resulted in significant predictors of SC-use across all three behavioral domains. Marijuana use (OR = 4.35; CI = 2.23 – 8.45), cocaine use (OR = 2.83; CI = 1.90 – 4.25), and opioid use (OR = 2.54; CI = 1.83 – 3.51) were statistically significant predictors in the substance use domain. Emotional neglect (OR = 1.94; CI = 1.22 – 3.09) was the only statistically significant predictor of SC-use in the interpersonal victimization domain, and clients meeting criteria for externalizing problems (OR = 1.52; CI = 1.12 – 2.10) was the statistically significant mental health predictor of SC-use.

Conclusions:

SC-use predictors included behavioral conduct issues, marijuana use and other drug use, and neglect/maltreatment histories. These predictors should be considered during clinical encounters with adolescents and in development of substance abuse prevention programs.